No image

MLH1 IHC pharmDx (Dako Omnis)

Details

Device typeMLH1 antigen IVD, antibody: One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used for the qualitative and/or quantitative detection of MLH1 antigen in a clinical specimen.

FDA categoryImmunohistochemistry test, DNA mismatch repair (MMR) Protein assay

Device ID05700575005213

MRI safetyLabeling does not contain MRI Safety Information

Total Volume12 Milliliter

Contact

Phone+1-800-227-9770

EmailGlobal.RA@agilent.com

Related products

Product	Model	Company	Device type
MSH2 IHC pharmDx (Dako Omnis)Agilent Technologies, Inc.MSH2 antigen IVD, antibody	GE085	Agilent Technologies, Inc.	MSH2 antigen IVD, antibody
PMS2 IHC pharmDx (Dako Omnis)Agilent Technologies, Inc.Postmeiotic segregation increased 2 (PMS2) IVD, antibody	GE087	Agilent Technologies, Inc.	Postmeiotic segregation increased 2 (PMS2) IVD, antibody
MMR Negative Control Reagent, Mouse (Dako Omnis)Agilent Technologies, Inc.Negative control immunoglobulin IVD	GE101	Agilent Technologies, Inc.	Negative control immunoglobulin IVD
VENTANA ANTI-MLH1 (M1) Mouse Monoclonal Primary AntibodyVentana Medical Systems, Inc.Hereditary nonpolyposis colon cancer (HNPCC) IVD, reagent	790-5091	Ventana Medical Systems, Inc.	Hereditary nonpolyposis colon cancer (HNPCC) IVD, reagent

Product	Model	Company	Device type